Drug Stocks Fall Prey to Insiders as Industry Shrugs Off Change

Brent Lewin/Bloomberg

Since 2007, 97 people charged or sued by U.S. regulators for insider trading gained their edge as a result of secret information about drugs, devices and the companies that make them, according to data compiled by Bloomberg.